Phase 2 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Parkinson's disease at a moderate to fairly advanced stage, confirmed by a specialist neurologist who reviewed a standardized video assessment of your movement
- You have trouble swallowing safely, meaning liquids may go toward your airway, or you have a weak cough that may not protect your lungs effectively (as measured by specific swallowing and cough tests)
- You are not currently taking part in any exercise-based swallowing therapy
- You are between 50 and 90 years old
Who may not be able to join:
- You have another neurological condition such as multiple sclerosis, a history of stroke, or a brain tumor
- You have a history of head or neck cancer
- You have a history of breathing conditions such as COPD or other lung/airway diseases
- You have smoked within the last five years
- You have high blood pressure that is not well controlled by treatment
- You have severe depression (scoring above 28 on a standard depression scale) or significant memory/thinking difficulties (scoring below 19 on a standard cognitive test)
- You have an allergy to capsaicin (the compound that makes chili peppers hot) or barium (a substance used in some swallowing tests)
- You live more than 1.5 hours away (door to door) from either Teachers College at Columbia University or Purdue University
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michelle Troche, PhD, Teachers College, Columbia University
Phone: 212-678-3072
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Peak Expiratory Flow Rate (Cough PEFR) - phase 1; Change in Peak Expiratory Flow Rate (Cough PEFR) - phase 2; Change in Penetration-Aspiration Scale (PAS) - phase 1; Change in Penetration-Aspiration Scale (PAS) - phase 2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.